Assay using hu-iPS-PE-device generated beta cells identifies compounds with positive effect on functional human beta cell mass

Milestone at month 18 sets proofofprinciple Equivalency with pancreatic human beta cells will be first examined Utility for screening libraries for compounds with this effect and thus for identifying agents for associated treatment to stem cell therapy